Patents by Inventor Roger Sessions

Roger Sessions has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7875294
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: January 25, 2011
    Assignee: Sessions Pharmaceuticals Inc.
    Inventors: Robert W. Sessions, Roger Sessions, legal representative, Alan R. Kahn
  • Patent number: 7756735
    Abstract: A process for developing Enterprise Architectures that results in a dramatic reduction in the complexity of the architecture and, therefore, in the cost of developing, implementing, and maintaining that architecture. The process is novel in that it is based on a mathematical model for complexity and how complexity can be reduced. The process for constructing enterprise architectures can also validate the architecture before it is implemented. The process begins by partitioning the Enterprise Architecture into autonomous subunits using the equivalence relation synergistic. It then uses type relations between these autonomous subunits to identify redundancies which can be simplified through consolidation. Once these autonomous subunits have been simplified as much as possible through consolidation, outsourcing, or functionality reduction, they are prioritized through risk/value analysis pictorially represented as Risk/Value Graphs.
    Type: Grant
    Filed: November 28, 2007
    Date of Patent: July 13, 2010
    Inventors: Roger Sessions, Beverly Bammel
  • Publication number: 20080126035
    Abstract: A process for developing Enterprise Architectures that results in a dramatic reduction in the complexity of the architecture and, therefore, in the cost of developing, implementing, and maintaining that architecture. The process is novel in that it is based on a mathematical model for complexity and how complexity can be reduced. The process for constructing enterprise architectures can also validate the architecture before it is implemented. The process begins by partitioning the Enterprise Architecture into autonomous subunits using the equivalence relation synergistic. It then uses type relations between these autonomous subunits to identify redundancies which can be simplified through consolidation. Once these autonomous subunits have been simplified as much as possible through consolidation, outsourcing, or functionality reduction, they are prioritized through risk/value analysis pictorially represented as Risk/Value Graphs.
    Type: Application
    Filed: November 28, 2007
    Publication date: May 29, 2008
    Inventors: Roger Sessions, Beverly Bammel
  • Publication number: 20070059251
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Application
    Filed: September 28, 2006
    Publication date: March 15, 2007
    Applicant: Ferris Pharmaceuticals, Inc.
    Inventors: Robert Sessions, Roger Sessions, Alan Kahn